These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35850405)

  • 21. Research Status of SARS-CoV-2 on Cardiovascular System Injury in Children.
    Zhang Y; Wang L; Wei S
    Braz J Cardiovasc Surg; 2021 Oct; 36(5):685-690. PubMed ID: 33355798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination.
    Kim SH; Lee SY; Kim GY; Oh JS; Kim J; Chun KJ; Ju MH; Lee CH; Song YJ; Na JY
    J Korean Med Sci; 2022 Apr; 37(13):e104. PubMed ID: 35380028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
    Gersh FL; O'Keefe JH; Henry BM
    Mayo Clin Proc; 2021 Mar; 96(3):820-821. PubMed ID: 33673933
    [No Abstract]   [Full Text] [Related]  

  • 24. SARS-CoV-2 infection markedly increases long-term cardiovascular risk.
    Liuzzo G; Volpe M
    Eur Heart J; 2022 May; 43(20):1899-1900. PubMed ID: 35362024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and myocarditis: a brief review.
    Taher F; Eysa A; Fahmy D; Shalaby A; Mahmoud A; El-Melegy M; Abdel Razek AAK; El-Baz A
    Front Biosci (Landmark Ed); 2022 Feb; 27(2):73. PubMed ID: 35227016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.
    Khalid N; Chen Y; Case BC; Shlofmitz E; Wermers JP; Rogers T; Ben-Dor I; Waksman R
    Cardiovasc Revasc Med; 2020 Aug; 21(8):946-949. PubMed ID: 32423791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Myocarditis: An Emerging Clinical Conundrum.
    Okor I; Bob-Manuel T; Price J; Sleem A; Amoran O; Kelly J; Ekerete MF; Bamgbose MO; Bolaji OA; Krim SR
    Curr Probl Cardiol; 2022 Sep; 47(9):101268. PubMed ID: 35644500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced cardiac imaging in the spectrum of COVID-19 related cardiovascular involvement.
    Palmisano A; Gambardella M; D'Angelo T; Vignale D; Ascione R; Gatti M; Peretto G; Federico F; Shah A; Esposito A
    Clin Imaging; 2022 Oct; 90():78-89. PubMed ID: 35930942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Siniorakis E; Arvanitakis S; Katsianis A; Nikolopoulos I
    J Korean Med Sci; 2021 Apr; 36(15):e113. PubMed ID: 33876590
    [No Abstract]   [Full Text] [Related]  

  • 30. Heart failure secondary to myocarditis after SARS-CoV-2 reinfection: a case report.
    Riedel PG; Sakai VF; Toniasso SCC; Brum MCB; Fernandes FS; Pereira RM; Baldin CP; Baldin CC; Takahasi AY; Shiki H; Krepsky AMR; Macedo DT; Merlo ÁRC; Rohde LEP; Joveleviths D
    Int J Infect Dis; 2021 Dec; 113():175-177. PubMed ID: 34688947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19.
    Parums DV
    Med Sci Monit; 2022 May; 28():e937048. PubMed ID: 35490309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis?
    Xiaoliang Yan ; Jing L; Deng Y
    Heart Surg Forum; 2020 Nov; 23(6):E895-E896. PubMed ID: 33253109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The COVID-19 pandemic: lifestyle and cardiovascular risk factors.
    Bhatnagar D
    Curr Opin Lipidol; 2021 Feb; 32(1):71-73. PubMed ID: 33315619
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
    Aleksova A; Fluca AL; Gagno G; Pierri A; Padoan L; Derin A; Moretti R; Noveska EA; Azzalini E; D'Errico S; Beltrami AP; Zumla A; Ippolito G; Sinagra G; Janjusevic M
    Life Sci; 2022 Dec; 310():121018. PubMed ID: 36183780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected Features of Cardiac Pathology in COVID-19 Infection.
    Fox SE; Li G; Akmatbekov A; Harbert JL; Lameira FS; Brown JQ; Vander Heide RS
    Circulation; 2020 Sep; 142(11):1123-1125. PubMed ID: 32689809
    [No Abstract]   [Full Text] [Related]  

  • 36. The cardiovascular legacy of the COVID-19 pandemic.
    Bhatt AS; Vaduganathan M
    Eur Heart J; 2022 Sep; 43(33):3179-3181. PubMed ID: 35680618
    [No Abstract]   [Full Text] [Related]  

  • 37. Should COVID-19 be considered cardiovascular disease risk equivalent?
    Kow CS; Ramachandram DS; Hasan SS
    Int J Cardiol; 2023 Apr; 377():123. PubMed ID: 36724830
    [No Abstract]   [Full Text] [Related]  

  • 38. Consequences of COVID-19 on the cardiovascular and renal systems.
    Zhu Y; Zhang X; Peng Z
    Sleep Med; 2022 Dec; 100():31-38. PubMed ID: 35994936
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective.
    Talasaz AH; Kakavand H; Van Tassell B; Aghakouchakzadeh M; Sadeghipour P; Dunn S; Geraiely B
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):249-259. PubMed ID: 32671601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
    Ritter O; Kararigas G
    Mayo Clin Proc; 2021 Mar; 96(3):821-822. PubMed ID: 33673934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.